Answers are grounded in this paper and cite their sources.
Industrial drug research is undergoing radical changes. Advances in molecular biology and gene technology have resulted in the development of test systems with which a very large number of substances can be screened for their biological activity. In order to keep pace with this high‐throughput screening procedure, preparative chemists need to reconsider conventional synthetic strategies.
No takes yet. Share an insight, caveat, or question.
Frobel et al. (1996) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: